0.30Open0.30Pre Close0 Volume1 Open Interest10.00Strike Price0.00Turnover264.01%IV91.09%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type0.2174Delta0.0947Gamma17.97Leverage Ratio-0.0264Theta0.0004Rho3.91Eff Leverage0.0035Vega
INmune Bio Stock Discussion
• $SpringWorks Therapeutics (SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences (ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen (OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Champion Homes (SKY.US)$ +4.4% (In reaction to earnings)
• $NetEase (NTES.US)$ +4.1% (In...
No comment yet